Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Moleculin Biotech, Inc. | Director | Stock option (right to buy) | 60K | May 25, 2023 | Direct | ||
Checkmate Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | May 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MBRX | Moleculin Biotech, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
MBRX | Moleculin Biotech, Inc. | Jun 20, 2022 | 2 | $0 | 4 | Jun 22, 2022 | Director |
CMPI | Checkmate Pharmaceuticals, Inc. | May 31, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
MBRX | Moleculin Biotech, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
MBRX | Moleculin Biotech, Inc. | Mar 1, 2022 | 0 | $0 | 3 | Mar 2, 2022 | Director |
CMPI | Checkmate Pharmaceuticals, Inc. | Dec 16, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
CMPI | Checkmate Pharmaceuticals, Inc. | Dec 16, 2021 | 0 | $0 | 3 | Dec 17, 2021 | Director |